Abstract

BackgroundBrain structural alterations and their clinical significance of myelin oligodendrocyte glycoprotein antibody disease (MOGAD) have not been determined.MethodsWe recruited 35 MOGAD, 38 aquaporin 4 antibody positive neuromyelitis optica spectrum diseases...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call